Dipharma Francis S.r.l. completes acquisition of Kalexsyn, Inc.

Dipharma Francis S.r.l., (Dipharma), a leading European manufacturer of Active Pharmaceutical Ingredients, is pleased to communicate that it has completed its previously announced acquisition of Kalexsyn, Inc. (Kalexsyn), a world-class Contract Research Organization (CRO) providing chemistry services to the biotechnology and pharmaceutical industry. Pursuant to an agreement dated March 19, Leggi tutto…